Post COVID-19 pulmonary complications; a single center experience

Ahmed, Okba F.; Kakamad, Fahmi H.; Amin, Bnar J. Hama; Abdullah, Berwn A.; Hassan, Marwan N.; Salih, Rawezh Q.; Mohammed, Shvan H.; Othman, Snur; Ahmed, Gasha S.; Salih, Abdulwahid M.

doi:10.1016/j.amsu.2021.103052

Cited by 18 publications

(17 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Pulmonary sequelae of COVID-19 are currently little understood; hence, information in this regard can help us in identifying the risk groups that need close follow-up. The development of pulmonary fibrosis is considered one of the key concerns regarding COVID-19 pulmonary sequelae as it is associated with architectural distortion of the lung parenchyma and overall impairment of lung function resulting in decreased quality of life [ 9 ]. Many studies have been conducted on PCPF; however, their results have been heterogeneous in some aspects.…”

Section: Discussionmentioning

confidence: 99%

“…This can be because of the angiotensin-converting enzyme 2 (ACE2)'s abundant presence in many organs of the body [ 8 ]. Even though it has been reported that most COVID-19 cases will fully recover after the infection, various new studies estimate that nearly 70–80% of the patients will continue to suffer from a wide range of short- or long-term post-infectious complications, especially in severe COVID-19 cases [ 9 , 10 ]. Pulmonary fibrosis is one of the more severe and frequently reported COVID-19 sequelae.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Post COVID-19 pulmonary fibrosis; a meta-analysis study

Amin¹,

Kakamad

Ahmed

et al. 2022

Annals of Medicine &Amp; Surgery

Self Cite

127

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Post COVID-19 pulmonary fibrosis; a meta-analysis study

Amin¹,

Kakamad

Ahmed

et al. 2022

Annals of Medicine &Amp; Surgery

Self Cite

127

View full text Add to dashboard Cite

“…In the case described above, all of these steps were taken, which allowed us to conclude that the haemoptysis resulted from the history of SARS-CoV-2 infection accompanied by chronic bronchitis. In addition, Ahmed et al [12] in their article also stated that haemoptysis may be one of the complaints reported by patients after recovery from this infectious disease. Among their study group, it was one of the three most common symptoms experienced by COVID-19 survivors.…”

Section: Discussionmentioning

confidence: 99%

Haemoptysis as symptom of SARS-CoV-2 infection – case study

Galle

Górka

Gałeczka‐Turkiewicz

et al. 2022

Ann. Acad. Med. Siles.

View full text Add to dashboard Cite

Od ponad dwóch lat lekarze i naukowcy zajmują się zagadnieniem COVID-19, czyli choroby wywołanej zakażeniem nowym koronawirusem SARS-CoV-2. Różnorodne objawy i powikłania COVID-19 nadal nie zostały poznane. W artykule przedstawiono przypadek 61-letniej kobiety z przewlekłym zapaleniem oskrzeli w wywiadzie, która po przebytym COVID-19 została przyjęta na Oddział Pulmonologiczny Samodzielnego Publicznego Szpitala Klinicznego nr 1 im. prof. Stanisława Szyszko w Zabrzu z powodu krwioplucia. Badania kliniczne, laboratoryjne i obrazowe wykazały, że krwioplucie najprawdopodobniej było skutkiem zapalenia dróg oddechowych. Chora była leczona antybiotykami, glikokortykosteroidami, lekami przeciwkrwotocznymi oraz przeciwkaszlowymi. W trakcie pobytu w szpitalu krwioplucie stopniowo ustępowało i pacjentkę wypisano do domu w bardzo dobrym stanie klinicznym.

show abstract

“…1 Other pulmonary complications like cavitary lung disease, bronchiectasis are also seen in addition to persistent symptoms such as dyspnea and fatigue. 2 , 3 The pulmonary sequelae are mostly seen in hospitalized patients with severe COVID-19 infection. 4 Asymptomatic COVID-19 patients developing lung fibrosis is an unheard-of entity.…”

Section: Introductionmentioning

confidence: 99%